In June 2012, Ms. Chen Yanling, CFO of CMS, was awarded ‘All-Asia Best CFO from Buy-Side in Health Care and Pharmaceuticals Sector in 2012’. This award was sponsored by Institutional Investor Magazine, and was voted on by 935 buy-side and 431 sell-side analysts, and it has a deep influence in Asia.
Institutional Investor magazine, with its headquarters in New York is one of the most influential financial magazines in the world. It is mainly used by the elites of Wall Street and other financial institutions in the world to provide research reports of industry and news analysis.
Our performance has continued to grow steadily since we were listed on the Main Board of Hong Kong Stock Exchange（“HKEx”）, and this award reflects the confidence of the capital market in the steady operation of our company. At the Meantime, we have adhered to good and effective communication with investors since our listing on the HKEx, and this award also displays the investors’ trust and confidence in the development of our company’s future.